The clinical settings of multiple cancer types exert several parameters such as tumor, nodes, and metastases (TNM) staging system, pathological type, clinical stage, and Nuclear-associated antigen ki-67 (Ki67) scores to divide patients into different risk groups for diverse therapeutic patterns (5–7). The gene discussed is MKI67; the disease is neoplasm.